Assam health department gears up to combat new COVID subvariant JN.1

Guwahati (Assam) [India], December 23 : The Assam Health Department has directed all hospitals in the state to make arrangements to fight against COVID after the detection of many cases of the new COVID subvariant JN.1.
Assam Health Minister Keshab Mahanta told ANI that "we are fully prepared to fight against COVID. We have directed all hospitals to make preparedness and arrangements to fight against COVID."
"After the meeting with the Union Health Minister, we alerted all hospitals. We have completed the preparations for the treatment of the COVID patient. Now we are 100 per cent prepared to fight COVID. One patient who came from abroad was detected as COVID-positive. Our government has given all support to the patient free of charge, and we have put the patient under observation," Keshab Mahanta said.
The Assam Health Minister further said that a sufficient number of ICUs, doctors, and testing kits are available in the hospitals of the state.
"We are fully prepared to fight with COVID," Keshab Mahanta said.
A multifold spurt in fresh COVID cases was noted in India over the past 24 hours, with Kerala contributing the majority of those.
A total of 423 cases were reported, of which 266 were from Kerala and 70 from neighbouring Karnataka, Union health ministry data showed.
Two deaths were reported in Kerala.
The total number of active cases of COVID-19 in the country was recorded at 3,420.
Meanwhile, amid rising concerns over the emergence of the new variant of the coronavirus, former World Health Organisation (WHO) chief scientist Dr Soumya Swaminathan asserted that there is no need to panic currently as it is a variant of interest and not of concern. However, she urged people to be cautious by taking proper precautionary measures.
Speaking exclusively to ANI, Dr Soumya Swaminathan, former DG of the Indian Council of Medical Research (ICMR), said, "We need to be cautious, but we don't need to worry because we don't have any data to suggest that this variant JN.1 is more severe or it's going to cause more pneumonia, more death."
The World Health Organisation (WHO) recently classified JN.1 as a variant of interest, distinct from its parent lineage, BA.2.86. However, the global health body emphasised that the overall risk posed by JN.1 remains low based on current evidence.
The number of new COVID cases increased by 52 per cent during the past four-odd weeks, the WHO said, with over 850 000 new cases reported during the period.
The number of new deaths decreased by 8 per cent as compared to the previous 28-day period, with over 3,000 new fatalities reported, the World Health Organisation (WHO) said in its latest press release.
As of December 17, over 772 million confirmed cases and nearly seven million deaths have been reported globally since the onset of COVID-19, the WHO noted.
Further, the WHO said over 118,000 new COVID-19 hospitalisations and over 1600 new intensive care unit (ICU) admissions have been recorded, with an overall increase of 23 per cent and 51 per cent, respectively, globally.
Due to its rapidly increasing spread, WHO is classifying the variant JN.1 as a separate variant of interest (VOI) from the parent lineage BA.2.86. It was previously classified as VOI as part of BA.2.86 sublineages.
Based on the available evidence, the additional global public health risk posed by JN.1 is currently evaluated as low. Despite this, with the onset of winter in the Northern Hemisphere, JN.1 could increase the burden of respiratory infections in many countries.
The WHO had earlier said it was continuously monitoring the evidence and would update the JN.1 risk evaluation as needed.
Current vaccines continue to protect against severe disease and death from JN.1 and other circulating variants of SARS-CoV-2, the virus that causes COVID-19, it noted.
COVID-19 is not the only respiratory disease circulating. Influenza, RSV, and common childhood pneumonia are also on the rise.
The WHO advises people to take measures to prevent infections and severe disease using all available tools. These include wearing a mask when in crowded, enclosed, or poorly ventilated areas, keeping a safe distance from others, practicing respiratory etiquette (covering coughs and sneezes), cleaning hands regularly, and getting tested if one has any symptoms or if you might have been exposed to someone with COVID-19 or influenza.